Thulium Fiber Laser vs. Holmium:YAG Laser for the Ureteroscopic Treatment of Patients With Urinary Stone Disease

IRCCS San Raffaele120 enrolled

Overview

This is a randomized controlled trial which aims to compare the efficacy and safety of Thulium fiber laser (TFL) and holmium:yttrium-aluminum-garnet (Ho:YAG) laser ablation during the treatment of upper urinary tract stone disease with flexible ureteroscopy, demonstrating clinical superiority of TFL.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

120

Conditions

Kidney Stone Ureteral Stone

Interventions

Laser lithotripsyDEVICE

Ureteroscopic laser lithotripsy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Renal/ureteral stones \> 4 mm Exclusion Criteria: * Anatomical abnormalities

Locations (1)

IRCCS Ospedale San Raffaele

Milan, Italy

RECRUITING

Outcomes

Primary Outcomes

Lithotripsy speed

Time frame: Through study completion, an average of 1 year

Secondary Outcomes

Stone free rate

Time frame: 3 months after the procedure

Central Contacts

D'Arma Alessia

CONTACT

+390226435506 darma.alessia@hsr.it

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.